Orazem J - Search Results

1

Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease.

Pettigrew LC, Bieber F, Lettieri J, Wermeling DP, Schmitt FA, Tikhtman AJ, Ashford JW, Smith CD, Wekstein DR, Markesbery WR, Orazem J, Ruzicka BB, Mas J, Gulanski B. Pettigrew LC, et al. Among authors: orazem j. J Clin Pharmacol. 1998 Mar;38(3):236-45. doi: 10.1002/j.1552-4604.1998.tb04421.x. J Clin Pharmacol. 1998. PMID: 9549662 Clinical Trial.

2

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B. Morris JC, et al. Among authors: orazem j. Neurology. 1998 May;50(5):1222-30. doi: 10.1212/wnl.50.5.1222. Neurology. 1998. PMID: 9595967 Clinical Trial.

3

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B. Cummings JL, et al. Among authors: orazem j. Neurology. 1998 May;50(5):1214-21. doi: 10.1212/wnl.50.5.1214. Neurology. 1998. PMID: 9595966 Clinical Trial.

4

Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial.

Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ, Deriesthal H. Padma-Nathan H, et al. Among authors: orazem j. Urology. 2003 Sep;62(3):400-3. doi: 10.1016/s0090-4295(03)00567-3. Urology. 2003. PMID: 12946731 Clinical Trial.

5

Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule.

Rigas JR, Francis PA, Miller VA, Tong WP, Roistacher N, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: orazem jp. Cancer Chemother Pharmacol. 1995;35(6):483-8. doi: 10.1007/BF00686832. Cancer Chemother Pharmacol. 1995. PMID: 7882456 Clinical Trial.

6

A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease.

Relkin NR, Reichman WE, Orazem J, McRae T. Relkin NR, et al. Among authors: orazem j. Dement Geriatr Cogn Disord. 2003;16(1):15-24. doi: 10.1159/000069988. Dement Geriatr Cogn Disord. 2003. PMID: 12714795 Clinical Trial.

7

Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants.

Stahl SM, Kaiser L, Roeschen J, Keppel Hesselink JM, Orazem J. Stahl SM, et al. Among authors: orazem j. Int J Neuropsychopharmacol. 1998 Jul;1(1):11-18. doi: 10.1017/S1461145798001059. Int J Neuropsychopharmacol. 1998. PMID: 11281940 Free article.

8

Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms.

Rosen RC, Seidman SN, Menza MA, Shabsigh R, Roose SP, Tseng LJ, Orazem J, Siegel RL. Rosen RC, et al. Among authors: orazem j. Int J Impot Res. 2004 Aug;16(4):334-40. doi: 10.1038/sj.ijir.3901197. Int J Impot Res. 2004. PMID: 14961048 Clinical Trial.

9

Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide.

Rigas JR, Tong WP, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: orazem jp. Cancer Res. 1992 Dec 1;52(23):6619-23. Cancer Res. 1992. PMID: 1423306 Clinical Trial.

10

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.

Francis PA, Rigas JR, Kris MG, Pisters KM, Orazem JP, Woolley KJ, Heelan RT. Francis PA, et al. Among authors: orazem jp. J Clin Oncol. 1994 Jun;12(6):1232-7. doi: 10.1200/JCO.1994.12.6.1232. J Clin Oncol. 1994. PMID: 7911159 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters